Denfivontinib Activates Effector T Cells Through the NLRP3 Inflammasome, Yielding Potent Anticancer Effects by Combination with Pembrolizumab. - Kim DK; Synn CB; Lee W; Jo HN; Lee CY; Lee S; Hwang JY; Kim Y; Kang SS; Baek S; Na K; Yang SM; et al. (Molecular cancer therapeutics, 2025)